Definitive vs palliative pelvic radiation for patients with newly diagnosed stage IVB cervical cancer treated with bevacizumab - An exploratory study.

Gynecol Oncol Rep · 2022 · PMC8956956 · PMID 35345549

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a definite trendno p-value reported

failed to reach significanceno p-value reported

With respect to progression free survival, a definite trend is noted in favor of definitive pelvic therapy in combination with bevacizumab containing chemotherapy, however the relationship failed to reach significance.

also in 427 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.